Minimum custom amount to enter is AED 2
By donating, you agree to the Privacy Policy and Terms of Service
The medicine “Jusprin 81 mg” has officially been shelved off by The Saudi Food and Drug Authority (SFDA) from being sold anywhere due to flaws found, announced SFDA via Twitter on Sunday.
If you or someone you know is currently taking medicine as upkeep, the SFDA has also told health authorities to stop using or prescribing the medication.
The organisation has also shared the report about this online, read it here.
(Image Credits: Twitter @saudi_fda)
خاطبت #الغذاء_والدواء الجهات الصحية لإيقاف استخدام مستحضر Jusprin 81mg الذي تنتجه شركة الخليج للصناعات الدوائية (جلفار)، وألزمت الشركة بسحب جميع تشغيلات المستحضر من الجهات المستفيدة. pic.twitter.com/xboTcARtbT
— هيئة الغذاء والدواء (@Saudi_FDA) January 21, 2019
The SFDA is advising patients using the medicine to seek their doctor’s advise and be prescribed something else in its place.
Information was received by the SFDA that the Jusprin 81 mg has quality flaws which has now resulted in it being withdrawn from all facilities that sell it.
If you have any questions or concerns about this, you may call the SFDA’s call center number: 19999
To which the SFDA responded, “You can learn about the alternatives through the Tra “We Care” mobile app via the interactive services” icon.
طيب وش البديل ؟!
— إيمان (@EmanMj2) January 21, 2019
The SFDA’s response: “There is no risk, the replacement is purchased or directed to the health side.”
يا دكتور توفيق لنا 3 سنوات نستخدم هذا الدواء عندي مرض القلب شنو الحل ؟????????????????????????????????????????????????
— Ahmed Alsaqr (@AhmedAlrahi) January 21, 2019
Minimum custom amount to enter is AED 2
By donating, you agree to the Privacy Policy and Terms of Service